ABUS vs AMGN: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Amgen Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.21
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | ABUS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $780.84M | $178.24B | AMGN |
| P/E Ratio | N/A | 25.58 | AMGN |
| EPS (TTM) | $N/A | $12.94 | AMGN |
| Revenue Growth | -0.6% | 0.1% | AMGN |
| Gross Margin | -98.9% | 70.1% | AMGN |
Analyze ABUS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or AMGN a better investment?
Comparing ABUS and AMGN: Arbutus Biopharma Corp has a market cap of $780.84M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and AMGN?
ABUS (Arbutus Biopharma Corp) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.6% for ABUS.
Which company is more profitable: ABUS or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.1% compared to -98.9% for ABUS.
Which is the larger company: ABUS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $780.84M for ABUS.
Should I buy ABUS or AMGN in 2026?
Both ABUS and AMGN have investment merit. ABUS trades at $4.21 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and AMGN stock?
Key differences: Market Cap ($780.84M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (-0.6% vs 0.1%), Gross Margin (-98.9% vs 70.1%).